Month: February 2022

US Authorizes New Antibody Drug to Fight Omicron

U.S. health regulators on Friday authorized a new antibody drug that targets the omicron variant, a key step in restocking the nation’s arsenal against the latest version of COVID-19. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he […]

Published on February 11, 2022

Study: COVID Booster Strength Wanes With Time, but Effective Against Hospitalization

An early look at the performance of COVID-19 booster shots during the recent omicron wave in the U.S. hinted at a decline in effectiveness, though the shots still offered strong protection against severe illness. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future […]

Published on February 11, 2022

Pfizer Postpones Application to FDA for COVID Vaccine for Kids Under 5

The U.S. Food and Drug Administration said it was postponing the advisory committee meeting to discuss request for authorization of Pfizer-BioNTech COVID-19 vaccine for children 6 months through 4 years of age. In a separate statement, Pfizer and BioNTech said they planned… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on February 11, 2022